Arvinas partners with Michael J Fox Foundation to drive new Parkinson disease research approaches

Arvinas partners with Michael J Fox Foundation to drive new Parkinson disease research approaches
Arvinas joins Parkinson research push

Arvinas has announced its participation in the Michael J Fox Foundation’s LITE and PPMI programs to support Parkinson disease research.

The company stated that these collaborations are aimed at deepening the understanding of LRRK2 biology, a key area of scientific investigation in Parkinson disease. By joining these initiatives, Arvinas seeks to contribute to the development of innovative new approaches for Parkinson disease and related conditions. Details on specific research milestones or timelines were not disclosed.

Arvinas recently delivered its first quarter 2026 financial results, reporting stable earnings. The company also provided a corporate update on its ongoing initiatives during the same announcement. These activities come as Arvinas expands its collaborations in Parkinson disease research.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.